<DOC>
	<DOCNO>NCT01161251</DOCNO>
	<brief_summary>Atrial fibrillation ( AF ) common sustain dysrhythmia encounter clinical practice North America Europe , account approximately one-third hospitalization cardiac rhythm abnormality . The presence AF markedly increase patient 's risk develop arterial embolism stroke , depend presence clinical condition , hypertension diabetes . AF associate fivefold increase risk stroke , estimate cause 15 % stroke . Patients AF frequently several risk factor atherosclerosis , include hypertension , diabetes , dyslipidemia . Accordingly , systemic sign atherosclerosis detect AF patient , likely account enhance risk coronary heart disease . In addition cerebrovascular disease , patient AF may suffer coronary event include myocardial infarction ( MI ) , rate MI AF patient seem variable , often underestimated . Moreover , coexistence peripheral arterial disease ( PAD ) relevant clinical sign systemic atherosclerosis . Ankle-brachial index ( ABI ) simple , inexpensive , non-invasive PAD measurement , even pre-symptomatic phase intervention improve prognosis prevent delay severe complication ABI calculate measure systolic blood pressure posterior tibial and/or dorsalis pedis artery either legs 1 leg choose random ( use Doppler probe alternative pulse sensor ) , low ankle pressure divide brachial systolic blood pressure . In addition peripheral artery disease , ABI also indicator generalized atherosclerosis low level associate high rate concomitant coronary cerebrovascular disease , presence cardiovascular risk factor . Two large study patient AF document existence PAD 3-5 % patient . It possible , however , incidence underestimated symptomatic patient consider affected PAD . As PAD important marker systemic atherosclerosis , association AF reinforces concept patient AF systemic atherosclerosis potentially account coronary complication . To date , national registry AF patient available verify real impact cardiovascular event clinical setting .</brief_summary>
	<brief_title>Atrial Fibrillation Registry Ankle-brachial Index Prevalence Assessment : Collaborative Italian Study .</brief_title>
	<detailed_description>Study design : Prospective longitudinal study Methods Materials : The investigator plan assess baseline schedule follow visit : 1 . Ankle-Brachial Index measurement 2 . Anamnestic clinical information Anthropometric measurements 3 . Echocardiogram ( volume size ) , electrocardiogram ( AF type ) 4 . Outcome event nonfatal fatal acute myocardial infarction , target lesion vessel revascularization nonfatal fatal ischemic stroke , transient ischemic attack , death cardiac vascular cause , death cause Study duration : 3 year follow-up Statistical method : The prevalence calculate exact confidence interval ( Wilson method ) . The cumulative incidence calculate product-limit estimator Kaplan-Meyer present confidence interval 95 % . The incidence prevalence adjust appropriate multivariate analysis ( use Cox proportional hazard model logistic model ) take account effect potential confounders . Similarly , effect-center presence check possibly remove . Secondary endpoint assess use Log-rank test method , Cox model ( time-dependent effect ) multivariate analysis . Subgroups analysis also conduct patient first onset AF recurrent AF Sample size : The investigator plan include study n = 3,000 AF patient , competitive recruitment center involve study . The sample size calculate assume expect prevalence 19 % time zero , order obtain confidence interval 95 % prevail time zero whose distance edge less equal 1.4 % . This sample size yield power great 99.9 % secondary endpoint , assume event rate 19 % patient ABI &lt; =0.9 , 10 % patient ABI &gt; 0.9.An interim analysis show ABI prevalence , calculate exact confidence interval , 21 % patient AF , consider interrupt enrollment , observe prevalence great two percentage point high assume . The sample size amend follow : sample 2027 patient lead expect prevalence 21 % confidence interval width 3.5 . This sample size impact power secondary objective .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Nonvalvular atrial fibrillation ( paroxysmal , persistent permanent ) Genders Eligible Study : Both Ages Eligible Study 18 year old Signed write informed consent Valvular AF Cancer Disease life expectancy le 3 year Pregnancy Hyperthyroidism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>ABI</keyword>
	<keyword>PAD</keyword>
	<keyword>Registry</keyword>
	<keyword>Italian</keyword>
</DOC>